Market News Call

Stocks Highlights: Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA), Hovnanian Enterprises, Inc. (NYSE:HOV), Zogenix, Inc.(NASDAQ:ZGNX)

Lakeway, NY — (MARKET NEWS CALL) — 3/07/2014— Specialpennystockalert.com, an investment community with a special focus on updating investors with recent news on the U.S. stock market about the small and penny stocks, issues news alert on Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA), Hovnanian Enterprises, Inc. (NYSE:HOV), Zogenix, Inc.(NASDAQ:ZGNX).

Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA)’s shares declined 2.45% to $8.37. The company on Feb. 25 reported financial results for the fourth quarter and full year ended December 31, 2013 and provided an update on corporate developments. Net loss for the fourth quarter ended December 31, 2013 was $74.2 million, or $0.40 per share, compared to a net loss of $60.5 million, or $0.36 per share, for the same period in 2012. Net loss for the full year 2013 was $274.2 million, or $1.49 per share, compared to a net loss of $220.9 million, or $1.34 per share, for the full year 2012.

Should Investors Buy ARIA After Yesterday’s Slump? Find Out Here

Hovnanian Enterprises, Inc. (NYSE:HOV)’s shares fell 4.04% to $5.22. The company on Mar. 5 reported results for its fiscal first quarter ended January 31, 2014. Total revenues were $364.0 million for the fiscal 2014 first quarter, an increase of 1.6% compared with $358.2 million during the first quarter of fiscal 2013. Net loss was $24.5 million, or $0.17 per common share, for the first quarter ended January 31, 2014, compared with a net loss of $11.3 million, or $0.08 per common share, in the last year’s first quarter, which included a $9.7 million federal tax benefit. Analysts polled by FactSet had expected a loss of 2 cents a share on revenue of $406 million.

Should Investors Buy HOV After Yesterday’s Slump? Find Out Here

Zogenix, Inc.(NASDAQ:ZGNX)’s shares decreased 14.48% to $3.84. The company on Mar. 5 reported financial results for the fourth quarter and full year ended December 31, 2013. Total revenues for the fourth quarter 2013, which consist of net product revenue and service and other revenue, were $9.9 million, up from $9.5 million in the fourth quarter 2012. Net loss for the fourth quarter 2013 was $35.6 million, or $0.28 per share, compared to a net loss of $0.6 million, or $0.01 per share, for the fourth quarter 2012. Net loss for the full year 2013 was $80.9 million, or $0.74 per share, compared to a net loss of $47.4 million, or $0.59 per share, for 2012.

Can Traders Buy ZGNX After The Solid Rally? Get Free Trend Analysis Here

About Specialpennystockalert.com

Specialpennystockalert.com is engaged in providing the most up to date and useful information on Microcap Stocks poised to breakout. Specialpennystockalert.com also provides investors with trend analysis, detailed company profiles, and most importantly a much needed “informational edge” which can be used as a tool for making investment decisions. To Receive Instant updates in the inbox, readers are advised to sign up for free at Specialpennystockalert.com.

Disclaimer

The assembled information disseminated by Specialpennystockalert.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Specialpennystockalert.com does expect that investors will buy and sell securities based on information assembled and presented in Specialpennystockalert.com. PLEASE always do your own due diligence, and consult your financial advisor.



Tags: , , , , ,

Comments are closed.